论文部分内容阅读
2015年欧洲联合胃肠病学周上,Norgine B.V.宣布该公司正在进行3项多中心随机平行对照三期研究,这三项研究分别是NOCT、MORA和DAYB。(源自:药品资讯网)
At the 2015 European Union Gastroenterology Week, Norgine B.V. announced that the company is conducting three multicenter randomized controlled phase III studies, NOCT, MORA and DAYB. (From: Drug Information Network)